U.S. stocks closed higher on Wednesday as investors digested the minutes from the Federal Reserve's meeting in January.
The Dow Jones Industrial Average increased 63.12 points, or 0.24 percent, to 25,954.44. The S&P 500 rose 4.94 points, or 0.18 percent, to 2,784.70. The Nasdaq Composite Index increased 2.30 points, or 0.03 percent, to 7,489.07.
The U.S. central bank said last month that it would be patient in tightening monetary policy moving forward and keeping interest rates unchanged.
"Participants pointed to a variety of considerations that supported a patient approach to monetary policy at this juncture as an appropriate step in managing various risks and uncertainties in the outlook," the minutes said.
The market is also closely monitoring the latest developments on China-U.S. trade talks.
On the earnings front, shares of CVS Health tumbled more than 8 percent to close at 64.22 U.S. dollars apiece after the company reported mixed quarterly earnings result.
It registered adjusted earnings per share of 2.14 dollars, higher than Wall Street's estimates. But its revenue fell short of expectations, standing at 54.4 billion dollars.
The Dow Jones Industrial Average increased 63.12 points, or 0.24 percent, to 25,954.44. The S&P 500 rose 4.94 points, or 0.18 percent, to 2,784.70. The Nasdaq Composite Index increased 2.30 points, or 0.03 percent, to 7,489.07.
The U.S. central bank said last month that it would be patient in tightening monetary policy moving forward and keeping interest rates unchanged.
"Participants pointed to a variety of considerations that supported a patient approach to monetary policy at this juncture as an appropriate step in managing various risks and uncertainties in the outlook," the minutes said.
The market is also closely monitoring the latest developments on China-U.S. trade talks.
On the earnings front, shares of CVS Health tumbled more than 8 percent to close at 64.22 U.S. dollars apiece after the company reported mixed quarterly earnings result.
It registered adjusted earnings per share of 2.14 dollars, higher than Wall Street's estimates. But its revenue fell short of expectations, standing at 54.4 billion dollars.
Latest comments